Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus

[1]  Adam R. Johnson,et al.  Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis. , 2017, JCI insight.

[2]  V. Pascual,et al.  Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis , 2016, Rheumatology.

[3]  A. Midgley,et al.  Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity , 2016, Lupus.

[4]  P. Merkel,et al.  Neutrophil‐Related Gene Expression and Low‐Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis , 2015, Arthritis & rheumatology.

[5]  J. Bienkowska,et al.  BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year , 2015, Lupus Science & Medicine.

[6]  Virginia Pascual,et al.  Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures , 2014, Arthritis & rheumatology.

[7]  S. Greenberg,et al.  The Plasma Cell Signature in Autoimmune Disease , 2014, Arthritis & rheumatology.

[8]  D. Isenberg,et al.  Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus. , 2013, Arthritis and rheumatism.

[9]  K. Elkon,et al.  Type I IFN system in the development and manifestations of SLE , 2012, Current opinion in rheumatology.

[10]  Gerald McGwin,et al.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[11]  Mariana J. Kaplan,et al.  Neutrophils in the pathogenesis and manifestations of SLE , 2011, Nature Reviews Rheumatology.

[12]  Matthias Kretzler,et al.  Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus , 2011, The Journal of Immunology.

[13]  V. Pascual,et al.  The interferon-α signature of systemic lupus erythematosus , 2010, Lupus.

[14]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[15]  Abdul Hakkim,et al.  Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis , 2010, Proceedings of the National Academy of Sciences.

[16]  W. Mccune,et al.  A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs , 2010, The Journal of Immunology.

[17]  M. Petri,et al.  Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus , 2009, Lupus.

[18]  P. Schneider,et al.  Cracking the BAFF code , 2009, Nature Reviews Immunology.

[19]  D. Gladman,et al.  Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus , 2008, Annals of the rheumatic diseases.

[20]  H. Nossent,et al.  B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time , 2006, Lupus.

[21]  Mimi Y. Kim,et al.  Combined oral contraceptives in women with systemic lupus erythematosus. , 2005, The New England journal of medicine.

[22]  D. Hilbert,et al.  B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels , 2005, Arthritis research & therapy.

[23]  P. Gregersen,et al.  The emerging role of interferon in human systemic lupus erythematosus. , 2004, Current opinion in immunology.

[24]  M. Peterson,et al.  Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus , 2004 .

[25]  V. Roschke,et al.  B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. , 2003, Arthritis and rheumatism.

[26]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[27]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  V. Roschke,et al.  Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. , 2001, Arthritis and rheumatism.

[29]  J. Kalbfleisch,et al.  Between- and within-cluster covariate effects in the analysis of clustered data. , 1998, Biometrics.

[30]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[31]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[32]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[33]  M. Peterson,et al.  Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[34]  M. Petri,et al.  Validity and reliability of lupus activity measures in the routine clinic setting. , 1992, The Journal of rheumatology.